SCHEMBL4369352

SCHEMBL4369352

CC(=O)OC[C@H]1OC(Oc2cc(C(=O)O)cc(O)c2O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.53
▸ CA2 P00918 3/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ USP2 O75604 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ TMPRSS2 O15393 1/20 0.53
▸ PDE5A O76074 1/20 0.53
▸ HMGCR P04035 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ LCK P06239 1/20 0.53
▸ FYN P06241 1/20 0.53
▸ HSPD1 P10809 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ TBXAS1 P24557 1/20 0.53
▸ MAPK3 P27361 1/20 0.53
▸ HSPE1 P61604 1/20 0.53
▸ MAPK14 Q16539 1/20 0.53
▸ TST Q16762 1/20 0.53
▸ SLCO1B3 Q9NPD5 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4368205 0.96 CYP2D6 (0.52) CA1CA2CYP2C9USP2MAPK1
SCHEMBL4375052 0.96 CYP2D6 (0.52) CA1CA2CYP2C9USP2MAPK1
SCHEMBL4367146 0.92 P4HB (0.48) CA1CA2CYP2C9USP2MAPK1
SCHEMBL4379633 0.92 P4HB (0.48) CA1CA2CYP2C9USP2MAPK1
SCHEMBL4366849 0.89 CYP2C9 (0.56) CA1CA2CYP2C9USP2MAPK1
SCHEMBL13587873 0.88 P4HB (0.47) CYP2C9USP2MAPK1CYP2D6THRB
SCHEMBL12651492 0.88 P4HB (0.47) CYP2C9USP2MAPK1CYP2D6THRB
SCHEMBL24297576 0.88 P4HB (0.52) CA1CA2CYP2C9CYP2D6THRB
SCHEMBL25721227 0.88 P4HB (0.52) CA1CA2CYP2C9CYP2D6THRB
SCHEMBL25785178 0.88 P4HB (0.52) CA1CA2CYP2C9CYP2D6THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622563-B2 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2009-11-24 — — US disclosed
US-20050272921-A1 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2005-12-08 — — US disclosed
EP-1544207-A1 PROCESS FOR PRODUCING GLYCOSIDE Mitsui Chemicals, Inc. (JP) 2005-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272921-A1 Process for producing glycoside HAAO, OGA, MGAM CA1 206/4885CA2 273/4885CYP2C9 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback